Questions for May 20 Presentation - Q&A
StudyLTCOVID.com
Thanks for visiting!
To translate this page, select your
language from the dropdown menu below:
Sent in your question yet?
Send to: Questions@StudyLTCOVID.com
Organizing a Question & Answer Session around a specific topic, implies that
participants will be at least aware enough of the subject to have questions.
If such awareness is not in evidence, presenting enough information to get everyone up to speed may of course take up all the time allotted, leaving no time for the Questions & Answers! (We have all probably assisted at such presentations).
Giving context to this Q & A process has been presented here on another page.
Our topic is the "long-term" variety of the COVID-19 illness, caused by infection with the SARS-CoV-2 virus.
Most will be aware of that entity. This illness began more than two years ago now, so a blend of things that are known, and others still to be learned is as true for "Long COVID" as for many other illnesses.
Information obtained from our questionnaire during the last quarter of 2020, ( ...way back then), continues to provide information that is foundational to an understanding of "long-term" COVID-19.
Those results continue to correctly inform questions that might be asked today.
But "dragging out" those results is itself a full presentation.
And in fact that was already done on November 27 of 2020, at the invitation of the Ethnicity and COVID-19 Research Consortium.
Pressed for Time?
(Who isn't ? ... )
Here is a suggestion about how to solve what is essentially both an information sharing and transfer problem, paired to a problem of time constraints: Those initial results are presented in the video summary below.
Having a look ahead of time (before May 20!) may help with formalizing one or more questions.
Duration: 10 minutes, 16 seconds. To be viewed at one's leisure.
(Perhaps with notepad and pencil in hand).
The answers we'll provide to present questions should not come only out of the above results.
Of course much has been learned beyond the limits of our initial work
Related work continues. Publications on COVID-19 and 'Long COVID' or PASC are exploding in number, as Google or ResearchGate can easily confirm.
And so to make our answers more complete, representative and accurate, references and citations from the present world of "long-term" COVID-19 as found in the appropriate literature will also be offered, and compiled here into a bibliography pertinent to those questions that people have already sent in, and others will be asking.
Some questions, of course may as yet have no known answer.
Others may have a proposed answer that we are not aware of. No surprises there either.
The published literature continues to blossom and flower each day.
And finally, some answers may be "ours" and may or may not agree with the sentiments and information presented in the current literature.
Whose opinion is being offered will also be presented where that seems indicated.
-----------
Depending on when you visit this page, the following may still be incomplete.
For those who use Zotero, information has also been shared via Group Name: "Long COVID - May 20"
A free version of Zotero is available for download at this link, but citations provided here and at the linked bibliography may suffice for your needs.
Question numbering below serves only to facilitate sorting in our question database and has no other meaning.
Below, an update here will soon add the actual questions and answers, where at present, only some of these are seen.
Q n° 1.0.1 Why is it called Long Covid?
Q n° 2.0.1 Are women more affected than men?
Q n° 2.0.2 What factors determine if someone will develop Long Covid?
Su, Y., Yuan, D., Chen, D.G., Ng, R.H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., Kornilov, S.A., Scherler, K., Pavlovitch-Bedzyk, A.J., Dong, S., Lausted, C., Lee, I., Fallen, S., Dai, C.L., Baloni, P., Smith, B., Duvvuri, V.R., Anderson, K.G., Li, J., Yang, F., Duncombe, C.J., McCulloch, D.J., Rostomily, C., Troisch, P., Zhou, J., Mackay, S., DeGottardi, Q., May, D.H, Taniguchi, R., Gittelman, R.M, Klinger, M., Snyder, T.M, Roper, R., Wojciechowska, G., Murray, K., Edmark, R., Evans, S., Jones, L., Zhou, Y., Rowen, L., Liu, R., Chour, W., Algren, H.A, Berrington, W.R., Wallick, J.A., Cochran, R.A., Micikas, M.E., the ISB-Swedish COVID19 Biobanking Unit, Terr
Wrin, Petropoulos, C.J., Cole, H.R., Fischer, T.D., Wei, W., Hoon, D.S.B., Price, N.D., Subramanian, N., Hill, J.A, Hadlock, J., Magis, A.T., Ribas, A., Lanier, L.L., Boyd, S.D., Bluestone, J.A., Chu, H., Hood, L., Gottardo, R., Greenberg, P.D., Davis, M.M., Goldman, J.D., Heath, J.R., Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae, Cell (2022), doi: https://doi.org/10.1016/j.cell.2022.01.014.
Q n° 2.2.1 From your experience, why are BAME/people of colour mostly affected by Covid19? And is this also the same for Long Covid?
Q n° 3.0.1 Are there reports about Long Covid in children following Covid-19 infections?
Q n° 7.0.1 What about vaccination and LTC?